The French laboratory Boiron, known for its homeopathic granules, now offers cosmetic products based on CBD.

“These treatments have been designed for muscle and joint comfort by combining the benefits of natural CBD with the pharmaceutical expertise of Laboratoires Boiron” according to the company.

The “CBD by Boiron” range is launched with the following 2 products which are now on the market:

• 1 gel cream which “helps regain flexibility and joint comfort”
• 1 gel to “relax muscles, promote physical relaxation and help recovery after exercise”

Made in France, these products are composed of 95% ingredients of natural origin, contain CBD isolate encapsulated in niosomes – nanoparticles used to pass the skin barrier – and from plants “grown in agriculture biological “.

The products have been distributed in pharmacies since the beginning of September.

This isn’t Boiron’s first foray into the cannabis sector. In its recent history, the laboratory is part of the experimentation with therapeutic cannabis as a substitute alongside the cannabis distributor Emmac (bought by Curaleaf) for CBD 20:1 and THC:CBD 10:10 oil.

Cresco Labs, an American cannabis seller present in several states and based in Chicago, is launching a new advertising campaign on the audio streaming service Spotify.

The campaign, which targets consumers in Illinois, will promote the Sunnyside cannabis dispensary chain, which is obviously owned by Cresco, through 30-second audio ads and digital banners on the Spotify app, according to a company press release.

“Audio streaming services represent a major opportunity for brands to reach large audiences in a targeted way, and we are excited to collaborate with Spotify to launch the first-ever cannabis ads for our national Sunnyside retail brand.” , said Cory Rothschild, national president of retail for Cresco Labs.

“Our advertising strategy for Sunnyside is built on a data ecosystem enabling best-in-class targeting and measurement. Spotify’s platform will allow our marketing team to compliantly and cost-effectively target our ads to our core customers in Illinois, where we have a leading retail presence. This important partnership is not only a step in the normalization of cannabis, but it also highlights the sophistication and quality of marketing we have in place at Cresco Labs. »

Spotify has more than 551 million users and 220 million subscribers worldwide.

“This important partnership is not only a step in the normalization of cannabis, but it also highlights the sophistication and quality of marketing we have in place at Cresco Labs,” said Cory Rothschild, National Sales President. details of the company, in the press release.

Cresco’s decision to advertise on Spotify comes at a time when Meta and Twitter have somewhat relaxed restrictions on cannabis and hemp businesses seeking to promote themselves on these platforms.

After his first 100 days as president, Moetai Brotherson announced this week that the plan to legalize CBD in Polynesia is ready.

The bill, known as Article LP3, establishes an innovative framework for the use and importation of hemp. Article LP3 authorizes the Polynesian population to “transport, import, export, hold, offer, sell, acquire, process and use products containing or derived from hemp seeds”. These products must be “devoid of narcotic properties”, that is to say that their THC content must for the moment be less than 0.3%.

In tropical Polynesian climates, however, Cannabis plants produce an explosion of phytocannabinoids, making it difficult for the local industry to maintain the 0.3% THC threshold set by French standards. The Polynesian Hemp Syndicate, under the impetus of its president, Philippe Cathelain, pleaded for this threshold to be raised to 1%, taking into account local conditions. This recommendation comes from an information mission of the French National Assembly, which insisted on the need for tolerance in the overseas territories, as is already the case for Reunion.

This new legislation has three essential components. In addition to the legalization of CBD, the Ministry of Agriculture has drawn up a second text relating to the cultivation and processing of hemp. But the most anticipated part is the third, which concerns medical cannabis. Beyond the anti-stress properties of CBD, medical professionals are especially interested in the pain-relieving potential of THC.

Philippe Dupire, pharmacist at the Center Hospitalier de Polynésie Française, points out to TNTV that THC can be valuable for treating stubborn pain and neurological diseases such as epilepsy. However, the text specifies that products containing hemp or cannabinoids can only be the subject of therapeutic claims if they obtain authorization as medicinal products. Currently, only three cannabis-based medicines are available in mainland France, and this new legislation will allow their importation into Polynesia.

The legislation provides exceptions for certain drugs, allowing their use “on an exceptional basis” when “the implementation of the treatment is likely to bring benefit to the patient” and that “the efficacy and safety of these drugs are strongly presumed in the state of scientific knowledge”. The Polynesian Council of Ministers will draw up a list of these exceptional drugs which will probably concern cannabis extracts and flowers.

The full bill is expected to be released to the public in “the next few days”.

Clever Leaves announced on August 29 that it had received the international declaration of carbon neutrality from the 100% Carbon Neutral program. The company thus generates only 16 kilograms of CO2 per kilogram of dried flowers2, while indoor cultivation practices generate up to 2,300 to 5,200 kilograms of CO2.

Clever Leaves representatives say it is the first vertically integrated medical cannabis company in the world to achieve international carbon neutral certification.

“At the heart of our business, we strive to be a sustainable company,” said Andrés Fajardo, CEO of Clever Leaves.

“We are among the first large, vertically integrated medicinal cannabis companies to operate in the newly legal sector, and it is our responsibility to build a sustainable and environmentally friendly industry from the start. We believe there is no better time than now to strengthen our commitment to sustainability and strive to mitigate climate change wherever possible. We take pride in knowing that our flowers and extracts sold worldwide are grown and manufactured in a carbon neutral environment. Furthermore, we believe it will also prove important for our customers, physicians and patients.”

Andrés Fajardo co-founded Clever Leaves in Colombia, leading the development of its first 18 hectares of cultivation and GACP and EU-GMP certified post-harvest facilities, as well as a GMP certified extraction and formulation plant.

Clever Leaves is not done, however, and will adopt passive techniques to harness solar energy and improve waste management practices. This also includes partnerships with local recycling associations, reforestation projects and the integration of rainwater. Thanks to these sustainable practices, the company reuses or recycles more than 50% of its waste.

Reducing the Cannabis Industry’s Carbon Footprint

To produce one kilogram of dried flowers, Clever Leaves only generates 16 kilograms of CO2, whereas traditional “indoor” cultivation methods generate up to 2,300 to 5,200 kilograms of CO2 per kilogram of dried flowers. The company’s energy consumption per kilogram of dried flowers is 62 kilowatt hours, which contrasts sharply with “indoor” use which can reach 5,000 kilowatt hours.

Clever Leaves has operations and investments in the United States, Canada, Colombia and Germany, and recently withdrew from Portugal.

Thanks to the deployment of sustainable practices, the carbon footprint of Clever Leaves amounted to 318 tonnes of carbon dioxide equivalent (CO2e) for all production operations in 2022. In addition, Clever Leaves has offset its remaining emissions by acquiring international carbon credits and supporting emission reduction projects.

“The fight against climate change requires everyone’s commitment, but especially that of leading companies in their sector. This is why working with Clever Leaves and making it the first Latin American company certified 100% Carbon Neutral® has been a very rewarding experience that strengthens Latin America’s fight against climate change,” said Javier Segura, COO for LATAM of the 100% Carbon Neutral Program®.

Canadian cannabis producer Hexo has also announced its ambition to be carbon neutral in 2021, mainly by offsetting its emissions rather than limiting them. On our side of the Atlantic, the Swiss company Naturalpes was recently certified B-Corp for having met rigorous social and environmental standards that represent its commitment to objectives other than shareholder profit.

A recent study published in the Journal of Cannabis Research revealed the extent of the presence of pesticides in illegal and legal cannabis in Canada.

In ” High levels of pesticides found in illicit cannabis inflorescence compared to licensed samples in Canadian study using expanded 327 pesticides multiresidue method“, the researchers compared 36 samples of cannabis from licensed dispensaries and 24 from illegal trade (which was seized by law enforcement and submitted to Health Canada and tested in the laboratory in 2021).

The researchers looked for traces of 327 different pesticides in the samples and found that many of the illegal cannabis samples contained harmful chemicals.

“Pesticides were detected in 92% of Canadian illicit cannabis inflorescence samples, with 23 unique pesticide active ingredients quantified,” the study explains. “Four pesticides and synergists: myclobutanil, paclobutrazol, piperonyl butoxide and pyrethrins, were detected at high sampling frequency, eight to 17 times out of a total of 24 illicit samples. »

They also noted that an illegal sample contained nine pesticide ingredients, but on average the illegal samples contained 3.7 different pesticides, with 87% of them containing more than one pesticide.

The researchers provided a table showing which pesticides were found in the legal and illegal samples. Only 6% of legal samples tested positive for pesticides, including only dichlobenil and myclobutanil.

Finally, they note that studies of this nature are not yet common. “To the authors’ knowledge, this study is the only in-depth multi-residue pesticide analysis that compares pesticides in the legal and illicit cannabis markets in a national jurisdiction where cannabis has been legalized,” the study concludes.

“Although this is a small study, our results support the Government of Canada’s message that consuming illegal products could lead to adverse effects and other serious harms. Tests carried out on illegal cannabis revealed the presence of contaminants such as pesticides and unacceptable levels of bacteria, lead and arsenic”.

UK CBD industry representatives are urging the Home Office to protect the sector and reassure millions of consumers with greater clarity and stricter regulation.
A new campaign, led by theAssociation for the Cannabinoid Industry (ACI), is asking the Home Office to put in place a legal framework covering the sale of CBD products, which it pledged to do in January 2021.

In the UK, CBD products have been sold online and in supermarkets for over a decade, despite the lack of official regulation. In recent years, they have become popular due to their potential health and well-being benefits, and around 18 million adults are said to consume them regularly.

In February 2020, the Food Standards Agency (FSA) unveiled detailed plans to regulate CBD as a food product. As a result, the industry has invested millions of pounds in research to comply with regulations.

In January 2021, the Ministry of the Interior sought the opinion of theAdvisory Committee on the Misuse of Drugs (ACMD) of the government to make the necessary changes to the Misuse of Drugs Act (Misuse of Drugs Act) with respect to the sale of CBD products.

After a year-long public consultation and call for evidence, the ACMD submitted a comprehensive report to the Home Office in December 2021, in which it sets out its recommendations on what would constitute an appropriate legal framework to allow the sale of CBD. Despite this, the Interior Ministry has yet to take any action.

A British industry in peril?

The Food Safety Authority currently regulates over-the-counter CBD products in England and Wales, with over 12,000 products authorized for sale by the FSA. The lack of legal clarity would prevent the FSA from granting authorizations for certain products considered novel foods, which would block the activities of companies and hinder innovation in the sector.

The UK CBD industry is estimated to be worth around £690million, but according to ACI the current uncertainty is putting the future of more than 400 businesses at risk.

In July, a Jersey-based CBD company, Jersey Hemp, was forced to close when the Home Office restricted the export of its products to the UK after it was found to contain traces of THC.

Industry leaders say the actions highlight the “vulnerability” of all companies operating in this sector.

The #SaveOurCBD campaign, launched on Monday 28 August, calls on the Home Office to urgently address this issue: “We call on the Home Office to provide urgent clarity regarding the establishment of a legal framework in which businesses can operate safely and responsibly. »

Steve Moore, #SaveOurCBD Campaign Representative and Senior Advocate for theAssociation for the Cannabinoid Industry, commented: “We understand the complexities facing the Home Office, but the companies have always acted responsibly throughout this period. There is no valid reason why the Home Office cannot provide the legal clarity the industry has been waiting for.”

The Ministry of the Interior will provide “more clarity” on the limits of controlled cannabinoids

The government is reportedly still considering the recommendations of the ACMD report.

In a statement to CannabisHealth, the Home Office has insisted it wants to provide “more clarity” to industry regarding the permitted limits set for controlled substances, such as THC, in herbal products. CBD. Businesses are also advised to seek legal advice on the activities they wish to undertake.

A spokesperson for the Home Office said: “This is a complex policy area and we are carefully considering the recommendations in the report of theAdvisory Council on the Misuse of Drugs (Advisory Council on Drug Abuse), who asked for advice on the matter. »

“We want to provide more clarity for responsible suppliers by introducing defined permitted limits for the content of controlled cannabinoids in consumer CBD products. This will make it easier for responsible suppliers to produce and supply consumer CBD products.”

Deli Hemp Pro, one of the leading CBD wholesalers, has established itself as a trusted platform for professionals in the CBD industry.

With a huge selection of premium CBD products and a series of customizable options, CBD wholesaler Deli Hemp Pro allows businesses to find high-quality CBD products and even create their own product line. The platform thus offers a white label service, allowing CBD shop owners to stock their store shelves with a diverse range of CBD products, including flowers, cosmetics and more.

Continuing the success of Deli Hemp with services adapted to professionals, the platform has introduced different offers. By partnering with Deli Hemp Pro, professionals can buy pre-packaged products, buy in bulk, or create their own brand of CBD products, tailored to their specifications. This innovative feature allows companies to establish a distinct identity in the competitive CBD market and offer quality products that resonate with their target audience.

This white label service allows CBD retailers to stock their stores with a diverse range of CBD products under their own brand. From CBD flowers to cosmetics, Deli Hemp Pro offers an extensive catalog of white-label products, allowing businesses to effortlessly furnish their stores with high-quality items that meet their customers’ needs.

Deli Hemp Pro’s commitment to quality is unwavering. The platform rigorously selects its suppliers, ensuring that all products meet the highest industry standards. This commitment to quality ensures that professionals working with Deli Hemp Pro can confidently offer their customers exceptional CBD products.

The CBD Supplier’s user-friendly interface makes it easy for professionals to navigate and find the products they need. With a wide range of CBD products available, including CBD oils, CBD flowers or CBD cosmetics, the platform offers a solution for CBD professionals looking to stock their stores with a diverse selection of CBD products.

“At Deli Hemp Pro, we strive to provide professionals in the CBD industry with a transparent and reliable experience,” said Dan Elmaleh, Founder of Deli Hemp. “We understand the importance of quality and customization in today’s market. Our platform offers professionals the opportunity to access top-notch CBD products and even build their own brand, helping them stand out in a crowded marketplace. »

As the CBD industry continues to thrive and evolve, Deli Hemp Pro remains committed to supporting professionals by providing a full range of quality CBD products and tailored solutions!

After the previous successful editions in Zurich, CB Expo returns this year to the Messe Dortmund, in parallel with the InterTabac trade fair. This three-day event includes trade shows, conferences and networking sessions, bringing together the closely related tobacco, vape and cannabis industries.

Newsweed being the media partner of the event, Newsweed readers benefit from a 20% reduction on their access tickets to CB Expo 2023, with the code cbexpo2023-newsweed.

A comprehensive cannabis program in Europe

The main stage will host exciting panel discussions on key topics such as legalization efforts in Germany and Europe, the Dutch ‘Weed Experiment’, operational efficiency and sustainability for (cannabis) businesses, investment in cannabis and the synergies between the tobacco and cannabis industries.

You can also dive into the depths of cannabis knowledge on the “Deep Dive Stage” and the “Education Stage”, with masterclasses and talks covering:

• CBD Sessions
• Cannabis Regulatory Sessions
• Cannabis Research Sessions
• Medical Cannabis Sessions
• Cannabis cultivation sessions

CB Expo calendar

Friday, September 15:
4 p.m. – 12 a.m. (reception at the Brauturm)

Saturday September 16:
4:00 p.m. – 6:00 p.m. (exhibition + conference at the Kongresszentrum)
From 6 p.m. – Aperitif networking + after party

Food and beverages are included in the price for all exhibitors, sponsors and visitors and smoking is permitted in the CB Lounge.

The price of the “Exhibition + Conference” ticket costs €190 and includes:

Access to CB Expo, Conferences, Network-Espace, Lounge and InterTabac*
Coffee, soft drinks, beer and snacks
Company profile featured in attendee list
Contact with all CB Expo participants via the events APP
Admission to InterTabac / InterSupply 2023

The price of the “Exhibition, Conference + Reception” ticket costs €290 and includes:

All of the above plus participation in the exclusive pre-event on Friday, September 15, including food and beverages.

Newsweed being the media partner of the event, Newsweed readers benefit from a 20% reduction on their access tickets to CB Expo, with the code cbexpo2023-newsweed.

The German Association of Cannabis Social Clubs (CSCD), founded last October, while welcoming the government’s intention to adopt the legalization of cannabis, rejects the government-approved bill, which it considers too strict and unnecessarily complex.

Unsere Position zum #CanRef is klar: #Cannabis Social Clubs sind immer Vereine, ideelle Gemeinschaften, nicht-kommerziell und basisdemokratisch.
Der Entwurf ist Prohibition 2.0 und verstärkt die Stigmatisierung, die es zu bekämpfen gilt.https://t.co/Dq9w878Wsw

— CSCDachverband (@CSCDachverband) August 30, 2023

Criticism of the bill and call for realistic adjustments

The CSCD protests against the current bill, which it considers constitutionally too strict and unnecessarily complicated. According to the association, the project gives a distorted image of cannabis users by presenting them as potential risk factors and attributing to them a propensity for illegal behavior.

The association believes that there is an urgent need to change the misrepresentation of cannabis users that has prevailed for a long time.

As democratically elected representatives of stakeholders, the CSCD earlier this week presented the “AltCanG” – an alternative bill for the controlled use of cannabis and amendments to other regulations. This proposal aims to avoid the shortcomings of the bill brought by the government and to make its implementation easier and more understandable for citizens.

Global approach to personal responsibility and health prevention

The AltCanG proposal, which can be found in full on their site, would allow adults to consume cannabis responsibly and independently.

Their bill authorizes private cultivation, non-commercial community cultivation and the controlled transfer of recreational cannabis to adults within associations. These provisions are based on those that apply to tobacco growing, which is more dangerous to health.

The proposal also encourages the reduction of bureaucracy in the management of industrial hemp and facilitates its economical use. At the same time, the commercial use of cannabis for non-medical purposes remains limited in order to avoid intoxication effects. Health risks would be reduced through information, advice and prevention, while education and prevention related to cannabis are specifically reinforced.

Will their proposal have an impact? At the beginning of last week, the German coalition parties indicated that they wanted to further modify and extend the cannabis law approved by the government, by adding the ediblesallowing consumption within Clubs and reducing penalties for possession, among other things.